Clin2
NCT07761546Worth exploringEnrolling by invitation

Ai-test: microbiome nutrition for low testosterone

Hypogonadism, MaleSecondary Hypogonadism

Part of Hormones & metabolism, Kidney & urinary, Mental health clinical trials.

This study tests whether a special diet can improve symptoms of low testosterone in men. It is intended to help men with certain symptoms like a low sex drive or trouble having erections and whose blood tests show low to borderline testosterone levels.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
112 people
Ages
30 years to 65 years
Study type
Interventional

Who can take part

  • Be a man aged 30 to 65 years old
  • Have had at least one sexual symptom (like low sex drive or erectile dysfunction) for at least 3 months
  • Have had two morning blood tests within the last few months that showed low-normal testosterone levels
  • Be in generally stable health without major medical conditions that are not well-controlled
  • Be willing to avoid taking testosterone or other sex-hormone medications for the 12-week study period

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07752511Not yet recruiting
How stigma affects quality of life in men with low testosterone

This study looks at how the stigma of having low testosterone affects men's sense of self and quality of life. By answering questionnaires, you can help doctors understand and better support men with this condition.

Bingoel
NCT07328542Not yet recruiting· Phase 4
Testosterone therapy and blood pressure monitoring in men

This study looks at how testosterone therapy affects blood pressure over 24 hours in men with low testosterone. It may help you understand how this treatment could affect your heart health.

Birmingham, Alabama
NCT05249634Recruiting· Phase 2
Testosterone treatment study for men with chronic kidney disease

This Phase 2 study tests whether testosterone therapy can help men with chronic kidney disease who have low testosterone and related symptoms. It looks to see if treatment is safe and beneficial, while carefully checking heart, blood, prostate, and clotting risks.

St Louis, Missouri
NCT07278362Not yet recruiting· Phase 4
Testosterone therapy for low testosterone with low-risk prostate cancer

This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are under active surveillance. It aims to see if treatment can help without worsening the cancer.

Miami, Florida
NCT06689085Recruiting· Phase 3
Testosterone replacement study for adolescent boys with low testosterone

This trial tests a testosterone injection (XYOSTED) to see if it's safe and effective for replacing testosterone in teenage boys who have low levels due to a known medical condition. It lasts 52 weeks, with an optional 2-year follow-up.

Los Angeles, California
NCT01894308Not yet recruiting· Phase 2
Testosterone gel for men with low testosterone

This trial tests a new testosterone gel at different doses to see how it affects men with low testosterone (below 300 ng/dL). It aims to find the right dose that safely and effectively raises testosterone levels in men aged 18-75.

London

Hear when a new Hypogonadism, Male trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.